INTRODUCTION
============

The ribosome is the central component of the translational apparatus. Its function is to decode the nucleotide sequence carried by the mRNA and convert it into an amino acid primary structure by the catalysis of peptide bonds ([@B34]). In eukaryotes, ribosomes consist of two different subunits: a 40S small subunit and a 60S large subunit. These two subunits exist as separate pools in the cytosol and when translation is initiated they assemble into an active 80S monosome suitable for elongation of the polypeptide chain ([@B46]; [@B1]). Ribosomal subunits contain both RNA and protein components. In mammals, the 40S subunit contains 33 different proteins and an 18S rRNA, whereas the 60S subunit is composed of 49 unique polypeptides and three rRNAs: a 5S, a 5.8S, and a 28S ([@B77]). In eukaryotes, ribosomal proteins (RPs) are assembled around the newly transcribed pre-rRNA within the nucleolus and then exported to the cytoplasm as mature subunits ([@B5]).

The small ribosomal subunit contains the decoding center in which aminoacyl-tRNAs base pair with the corresponding codons in the mRNA ([@B57]; [@B76]). The peptidyl transferase center is located in the large subunit and rRNA is the sole enzyme responsible for this catalytic activity ([@B39]; [@B4]; [@B38]; [@B26]). Ribosomal proteins are thought to have mainly a scaffolding/chaperone role in facilitating the processing and folding of rRNA during biogenesis and stabilizing the mature particle during protein synthesis ([@B19]).

Translation factors are additional elements of the protein synthesis machinery that associate transiently with the ribosome ([@B47]). In general, they function by coupling ATP or GTP hydrolysis to the conformational rearrangements that occur during ribosomal motion (scanning and translocation; [@B34]). It has been well established that global regulation of protein synthesis in eukaryotes is mainly achieved by posttranslational modification (PTM) of translation factors in response to environmental cues ([@B22]). Mammalian ribosomal proteins also bear many different PTMs such as acetylation, methylation, ubiquitination, and phosphorylation among others ([@B40]; [@B79]). However, the impact of ribosomal protein modification on ribosome assembly, performance, or translation has not been studied. Recent studies suggest that ribosomal protein modification seems to play an important role in the extraribosomal functions of some individual riboproteins ([@B61]; [@B35]; [@B56]).

Several proteins of the translational machinery, including core ribosomal proteins, were identified as *O*-GlcNAc--modified in global glycoproteomic studies ([@B28]; [@B71]; [@B23]; [@B66]). *O*-GlcNAcylation is a PTM present in certain bacteria and in all metazoans, in which the *O*-linked monosaccharide β-*N*-acetylglucosamine cycles dynamically on serine or threonine residues of nuclear and cytoplasmic proteins ([@B27]). Two highly conserved enzymes catalyze the cycling of *O*-GlcNAc on proteins: the adding enzyme *O*-GlcNAc transferase (OGT; uridine diphospho-*N*-acetylglucosamine:polypeptide β-*N*-acetyl-glucosaminyltransferase; [@B24]), and the removing enzyme β-*N*-acetylglucosaminidase *O*-GlcNAcase (OGAse), a neutral hexosaminidase ([@B18]; [@B20]). *O*-GlcNAc cycling plays an important role in many fundamental processes of cell physiology. *OGT* is essential for embryonic stem cell viability and is required for somatic function in several mammalian adult cell types. *O*-GlcNAcylation is a direct regulator of cellular growth and proliferation, protein turnover, and cellular stress, among others. The role of *O*-GlcNAc in cellular function is partly mediated by a complex interplay with phosphorylation that is substrate-dependent. *O*-GlcNAc and phosphate can compete for the same site on a protein. Alternatively, the two modifications can reciprocally occupy different sites (adjacent or distant) on a protein or coexist on another. In addition, each modification regulates the other\'s cycling enzymes. This cross-talk provides the cell with a mechanism to create great molecular diversity in response to stimuli and fine-tune protein interactions and functions ([@B27]; [@B70]).

Little is known with respect to the functional consequences of the *O*-GlcNAc modification on translational proteins or on the process of protein synthesis itself. *O*-GlcNAc seems to play an important role in protein stabilization and cellular protection during stress. *O*-GlcNAcylation of the eIF2-associated factor p67 (which protects eIF2 from phosphorylation by heme-regulated kinases) prevents p67\'s degradation and stabilizes the protein allowing its association with eIF2. In contrast, non-*O*-GlcNAcylated p67 is rapidly degraded, resulting in phosphorylation of eIF2 and translation inhibition ([@B13], [@B14], [@B15]; [@B49]). In a recent study, the *O*-GlcNAcylation of ribosomal proteins was found to increase rapidly upon arsenite treatment, and OGT was required for stress granule formation during these conditions ([@B42]).

In this report, we describe the incidence of the *O*-GlcNAc modification on purified translational preparations by direct methods. We identify several core ribosomal proteins as substrates for *O*-GlcNAcylation and map sites of modification on four of these proteins. In addition, we show that OGT and OGAse associate with different subpopulations of ribosomes and these interactions may play roles in ribosome biogenesis and translational regulation.

MATERIALS AND METHODS
=====================

Cell Culture and Treatments
---------------------------

HepG2 human hepatoma cells were maintained in minimum essential medium (Mediatech, Herndon, VA) supplemented with 10% vol/vol fetal bovine serum (Gemini Bio-Products, Woodland, CA) and penicillin/streptomycin. HeLa human adenocarcinoma cells and HEK293 human embryonic kidney cells were maintained in Dulbecco\'s modified Eagle\'s medium (Mediatech) (20 mM glucose) supplemented with 10% vol/vol fetal bovine serum and penicillin/streptomycin. Neuro2a murine neuroblastoma cells were maintained in Dulbecco\'s modified Eagle\'s medium (5 mM glucose) supplemented with 10% vol/vol fetal bovine serum and penicillin/streptomycin. All cell lines were maintained at 37°C in a humidified incubator with 5% CO~2~.

Glucose deprivation treatment of Neuro2a cells was performed exactly as previously described ([@B9]). For immunofluorescence experiments nucleolar stress was induced by treating HeLa cells with actinomycin D (Sigma, St. Louis, MO; 0.5 μg/ml final concentration, 1 h), whereas control cells were treated with vehicle (DMSO, Sigma, 1:1000 vol/vol dilution).

Antibodies
----------

For immunoblotting, the following commercially available primary antibodies were used at 1:5000 dilution: *O*-GlcNAc (CTD110.6, Covance Laboratories, Madison, WI), hemagglutinin (HA; Covance; HA.11), S6 ribosomal protein (2217, Cell Signaling Technology, Beverly, MA), phospho-S6 ribosomal protein (Ser235/236; 2211, Cell Signaling Technology), actin (Sigma), tubulin (Sigma), and fibrillarin (5821, 4566, Abcam, Cambridge, MA). Polyclonal antibodies for OGT (AL-28) and OGAse (345, 346) were raised in rabbit and chicken, respectively, and were also used at a 1:5000 dilution. Horseradish peroxidase (HRP)-conjugated secondary antibodies were obtained from GE Healthcare (Piscataway, NJ; rabbit: NA934V, mouse: NA931V) or Sigma (chicken: A 9046 and anti-mouse IgM: A 8786). For immunofluorescence studies, final dilutions were 1:1000 for OGT (AL-28), OGAse (345, 346), and tubulin antibodies, 1:100 vol/vol for S6 ribosomal protein (2317, Cell Signaling Technology) and 1:200 or 1:500 for fibrillarin (5821, 4566). Isotype controls for OGAse were performed with normal chicken IgY (sc-2718, Santa Cruz Biotechnology, Santa Cruz, CA). Fluorescently labeled secondary antibodies Alexa Fluor 647, 568, 546, and 488 were purchased from Invitrogen-Molecular Probes (Eugene, OR).

Plasmid- and Adenovirus-mediated Overexpression
-----------------------------------------------

Mammalian expression vectors encoding HA-tagged ribosomal protein S6 wild-type and phosphorylation mutants (HA-S6, HA-S6-Ser235/236S, and HA-S6-Ser235/236D) and HA (empty vector) were a kind gift of Dr. Philippe R. Roux (Université de Montréal, Montréal, QC, Canada; [@B53]). HEK 293 cells were transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to manufacturer\'s instructions. Cells were infected at a multiplicity of infection of 25 for OGAse and 50 for OGT and GFP adenovirus 48 h before harvesting ([@B60]).

Purification of Different Ribosomal Subpopulations and Isolation of Nucleoli
----------------------------------------------------------------------------

A total ribosome preparation was obtained from rat livers (PelFreez, Rogers, AR) or cells in culture as follows. Livers were thawed in ice-cold phosphate-buffered saline for 30 min and then homogenized in TMK buffer (50 mM; Tris-HCl, pH 7.5, 5 mM MgCl~2~, 100 mM KCl) supplemented with 1% Triton X-100 (Sigma), 1 μM *O*-GlcNAc-thiazoline (GT; [@B31]; synthesized in house), 100 μg/ml cycloheximide (Sigma), 2 mM phenylmethylsulfonyl fluoride, and protease and phosphatase inhibitors with ∼15 strokes in a manual Potter-Elvehjem Dounce homogenizer (30 ml of buffer per liver). HepG2 or HeLa cell pellets were lysed in TMK buffer supplemented with 1% Triton X-100 (Sigma), 1 μM GT, 100 μg/ml cycloheximide, 2 mM phenylmethylsulfonyl fluoride, and protease and phosphatase inhibitors (∼3 × 10^8^ cells/30 ml buffer) by pipetting up and down several times. After 15 min on ice, tissue homogenates or cell lysates were spun in a 70.1 Ti rotor (Beckman Coulter, Fullerton, CA) at 14,000 rpm for 30 min at 4°C. The resulting postmitochondrial fractions were loaded onto 1 M sucrose cushions prepared in TMK buffer supplemented with 100 μg/ml cycloheximide and 1 μM GT at a 1:1 ratio. Samples were subjected to ultracentrifugation at 41,000 rpm in SW41 Ti rotor for 3 h at 4°C. The resulting supernatants were saved as postribosomal fractions, and the ribosomal pellets were washed three times and resuspended with a pestle in 1 ml of TMK buffer. Only ribosomal preparations with OD~260/280~ \> 1.8 were used for further experiments.

For salt-wash procedures, 100 μl of ribosomes were resuspended in TMK buffer containing 0.1, 0.25, 0.5, 0.75, or 1 M KCl, 100 μg/ml cycloheximide, and 1 μM GT and incubated for 30 min at 4°C with constant rotation. Then, ribosomes were pelleted through a sucrose cushion as described above.

For polysome profiles HepG2 cells were lysed as described above with the addition of 40 U/ml RNAse out (Promega, Madison, WI) and centrifuged at 6000 rpm for 15 min in a refrigerated centrifuge. Supernatants were loaded onto a continuous 15--60% sucrose gradient (10 ml) in TMK buffer supplemented with 1 μM GT and 100 μg/ml cycloheximide and subjected to ultracentrifugation at 38,000 rpm in SW41 Ti rotor for 2 h at 4°C. Gradients were fractionated using a Brandel fractionator and absorbance at A~254~ nm was continuously recorded.

The procedures for isolation of nucleoli were performed as previously described ([@B64]; [@B3]).

Protein Extraction and Precipitation
------------------------------------

Proteins from total ribosome preparations were extracted by adding 1/10 volume of 1 M MgCl~2~ and 2 volumes of acetic acid in rapid succession and incubating 45 min at 4°C with constant rotation. rRNA was precipitated by centrifugation at 14,000 rpm for 15 min and the proteins in the supernatant were precipitated with 10 volumes of cold acetone for 2 h at −20°C. After three washes with acetone the protein pellet was air-dried and resuspended in 1% SDS or 8 M urea and subjected to protein estimation by the bichoncinic acid method (Pierce, Rockford, IL).

Proteins from nucleoli were extracted with Trizol (Invitrogen) according to manufacturer\'s instructions before protein estimation analysis.

Proteins from sucrose gradient fractions (1 ml) were precipitated by adding 10 μl of 0.1% bovine serum albumin (BSA) and 100 μl of trichloroacetic acid (TCA) and incubating on ice for 1 h. Samples were spun at 12,000 rpm for 15 min. Pellets were recovered and washed twice with ethanol by incubation for at least 30 min on ice and centrifugation at 12,000 rpm for 5 min. Samples were air-dried and resuspended in Laemmli buffer for electrophoresis.

Protein Analysis
----------------

For immunoprecipitation experiments, cell pellets were lysed with 1% (vol/vol) Nonidet P-40 (Sigma) in phosphate-buffered saline supplemented with 1 μM GT, 2 mM phenylmethylsulfonyl fluoride, and protease and phosphatase inhibitors. Lysates were centrifuged at 14,000 rpm for 15 min to remove debris. Samples (1 mg/ml) were incubated overnight at 4°C with 1 μg of primary antibody. GammaBind G-Sepharose beads (GE Healthcare) were added and mixed for an additional 2 h at 4°C. The immunoprecipitates were washed, resuspended in Laemmli buffer, and subjected to immunoblot analysis.

For immunoblot analysis, samples were mixed with Laemmli buffer, boiled, separated on SDS-polyacrylamide gels (Bio-Rad, Richmond, CA) and transferred to polyvinylidene difluoride membrane (Millipore, Bedford, MA). Membranes were blocked for 1 h at room temperature (RT) in Tris-buffered saline with 0.1% (vol/vol) Tween-20 containing either 3% (wt/vol) BSA or 5% (wt/vol) nonfat dry milk. Membranes were then incubated overnight at 4°C with the appropriate antibody primary antibody and subsequently with the respective secondary antibody for 1 h at RT. Blots were developed using enhanced chemiluminescence (ECL; GE Healthcare) and exposed to Hyperfilm ECL (GE Healthcare). Blots were stripped in 200 mM glycine, pH 2.5, for 1 h at RT and reprobed using different antibodies.

For lectin blots, membranes were blocked as before and incubated with HRP-conjugated succinylated wheat germ agglutinin (sWGA; 2102-1, EY Laboratories, San Mateo, CA) for 1 h at RT. Membranes were washed in high-salt Tris-buffered saline (0.5 M NaCl) and developed as described for immunoblotting.

Galactosyltransferase Labeling
------------------------------

In the case of postmitochondrial and postribosomal fractions from rat pancreas, samples were denatured before labeling by incubating with 10 mM DTT and 0.5% (wt/vol) SDS and boiling for 10 min. For labeling, samples were diluted with 10 volumes of buffer containing 50 mM HEPES, pH 6.7, 50 mM NaCl, and 2% Triton X-100. Reactions were set up by mixing the sample with 10× galactosyltransferase labeling buffer (100 mM HEPES, pH 7.5, 100 mM galactose, and 50 mM MnCl~2~), 5′-AMP, 1 μCi UDP-\[^3^H\]Gal (American Radiolabeled Chemicals, St. Louis, MO; ART 0131), 1 U β-1,4-galactosyltransferase (Sigma, 48279) that had been previously autogalactosylated with cold UDP-Gal, and 1 U calf intestinal alkaline phosphatase (New England BioLabs, Beverly, MA) and incubating overnight at 4°C. Reactions were stopped by the addition of Laemmli buffer. Samples were boiled and separated by electrophoresis as described. Gels were stained with Coomassie brilliant blue G-250 (Bio-Rad) for total protein detection, and incubated in En^3^Hance solution (6NE9701, Perkin Elmer-Cetus, Boston, MA) for 1 h at 25°C upon destaining. The gels were then soaked in 1% (vol/vol) glycerol, dried, and exposed to film at −80°C. Where indicated, samples were treated with jack bean hexosaminidase (Sigma) for 18 h at 25°C before galactosyltransferase labeling.

Reverse-Phase HPLC
------------------

Proteins from total ribosomes were extracted in 3 vol of 6 M GuHCl followed by 4 vol of 0.2% trifluoroacetic acid for 1 h at 4°C with constant rotation. The insoluble rRNA was precipitated by centrifugation at 14,000 rpm for 15 min at 4°C. Protein extracts were separated in a Smart System (Pharmacia Biotech, Arlington Heights, IL). One milligram of sample was injected into a C8 column (Vydac, Hesperia, CA) and eluted at 25°C by a gradient of buffer A (0.1% trifluoroacetic acid in water) and buffer B (0.09% trifluoroacetic acid in 75% acetonitrile) for 90 min, with a flow rate of 100 μl/min. Detection was simultaneously monitored at 214, 260, and 280 nm. Approximately, 60 fractions of 150 μl were collected, dried in a speed-vac, resuspended in Laemmli buffer, and examined by one-dimensional gel electrophoresis.

Immunofluorescence Microscopy
-----------------------------

HeLa cells were fixed, permeabilized, and stained as previously described ([@B59]). Fluorescent images were obtained on the 3i Spinning Disk Confocal microscope using the Olympus Slidebook software (Melville, NY) at the Johns Hopkins University School of Medicine Core Microscopy Facility.

Site Mapping and Protein Identification
---------------------------------------

For site mapping, proteins extracted from total ribosome preparation were digested with Endoproteinase Lys-C (Roche, Indianapolis, IN) and tagged as described before ([@B71]). *O*-GlcNAc peptides were enriched by avidin chromatography and derivatized by BEMAD ([@B73]). The derivatized peptides were separated by a reverse-phase C18 column (5 μm, 120 Å, YMC ODS-AQ, Waters, Milford, MA) connected to an Eksigent nano-LC system (Dublin, CA). The main HPLC gradient was 5--40% solvent B (A, 0.1% formic acid; B, 90% acetonitrile, 0.1% formic acid) in 60 min at a flow rate of 300 nl/min. Mass spectrometric analysis was performed by a linear trap quadrupole (LTQ)-Orbitrap (Thermo Scientific, Waltham, MA). Briefly, each survey scan (FT-MS, 60,000 resolution at m/z 400) of m/z 400-2000 was followed by CAD fragmentation of up to the five most intense precursor ions. Normalized collision energy was set at 35%. Dynamic exclusion was enabled with repeat count of 2 in 30 s and exclusion duration of 60 s. Database search was performed by using Mascot Daemon (version 2.2.0; Matrix Science, Boston, MA) against the Swiss-Prot database with the following parameters: enzymes, Lys-C; variable modifications, deamidated (NQ), DTT (ST); max missed cleavages, 2; peptide mass tolerance, 0.1 Da; and fragment mass tolerance, 0.8 Da.

For protein identification, bands were excised and digested in-gel with Trypsin (Promega) or endoproteinase Lys-C. Peptides were extracted with 0.1% trifluoroacetic acid, 60% acetonitrile, and dried in a speed-vac. In the case of Hela cells, the extracted peptides were subjected to vMALDI-LTQ (1.0, Thermo Electron, Franklin, MA) analysis at the Johns Hopkins University Proteomics Core Facility and search was performed using Mascot against the National Center for Biotechnology Information database. In the case of rat liver, extracted peptides were analyzed by LTQ-Orbitrap (Thermo Scientific) as described for site mapping. Raw data were analyzed using Mascot (Matrix) as for site mapping, except no DTT(ST) was selected as variable modification. Only proteins with at least two significant and unique peptides are included in the results.

Statistical Analysis
--------------------

Protein band densitometry from Western blots was measured using the software ImageJ (<http://rsb.info.nih.gov/ij/>). Statistical differences were determined by a one-tail, paired Student\'s *t* test and were considered significant when p = 0.07.

RESULTS
=======

The O-GlcNAc Modification Is Part of the Translational Machinery
----------------------------------------------------------------

Several components of the translational machinery have been identified as *O*-GlcNAc modified proteins in different high-throughput studies using complex mixtures (i.e., whole-tissue homogenates or total-cell lysates) as a starting material ([@B28]; [@B71]; [@B23]; [@B66]). We set out to determine the extent and abundance of *O*-GlcNAcylation in subcellular fractions rich in translational components. We first selected rat pancreatic tissue based on its high amount of *O*-GlcNAc modified proteins ([@B2]; [@B25]), fractionated it into postmitochondrial, postribosomal, and ribosomal preparations and performed galactosyltransferase reactions using UDP-\[^3^H\]Gal to label terminal *O*-GlcNAc moieties ([@B75]). As expected, the postmitochondrial and postribosomal fractions contained many proteins that were strongly labeled ([Figure 1](#F1){ref-type="fig"}A). Interestingly, the ribosome-rich fractions also showed labeling of several bands ([Figure 1](#F1){ref-type="fig"}A, arrowheads), indicating that components associated with the translational machinery are modified with *O*-GlcNAc. Reactions excluding galactosyltransferase were included as controls ([Figure 1](#F1){ref-type="fig"}A). To obtain the purest possible ribosomal preparations, we then fractionated rat liver tissue. Translational preparations showed intense labeling of many low-molecular-weight proteins ([Figure 1](#F1){ref-type="fig"}B), coinciding with the typical ribosomal proteins masses. Pretreatment with commercial hexosaminidase for 18 h before labeling partially decreased the signal ([Figure 1](#F1){ref-type="fig"}B). This enzyme removes terminal β-GlcNAc and *O*-GlcNAc and is commonly used as a specificity control for galactosyltransferase reactions ([@B75]); however, its optimal low pH (4--5) often contributes to protein degradation during longer times of incubation.

![Preparations enriched in ribosomal components contain numerous *O*-GlcNAc proteins. (A) Postmitochondrial (PM), postribosomal (PR), and ribosomal (Ribo) preparations were obtained by subcellular fractionation of rat pancreas and subjected to galactosyltransferase labeling in the presence of UDP-\[^3^H\]Gal. Top, autoradiographs of the gels stained with G250 seen in the bottom panels. Many *O*-GlcNAcylated low-molecular-weight proteins (\<50 kDa) are observed in the Ribo preparation (arrowheads). No substrate (NS) and positive ovalbumin (Ovb) controls are included. Reactions containing all the components except galactosyltransferase (−GalT) are shown in the top right panel. (B) Ribosomal preparations from rat liver were obtained and labeled as in A. Partial pretreatment with commercial hexosaminidase (Ribo+Hex) decreases labeling by galactosyltransferase. (C) Fractions from polysome profiles (top panel) obtained from HepG2 cells growing under normal conditions were TCA precipitated, separated by electrophoresis, and subjected to immunoblot (IB) analysis with *O*-GlcNAc antibody (middle). A competition control obtained by pre-incubating the antibody with 1 M GlcNAc shows specificity of the labeling (bottom). Sedimentation was from left to right. Data shown are representative of at least three independent experiments.](zmk0121094710001){#F1}

Ribosomal preparations purified under these conditions are translationally competent when incubated in vitro with exogenous mRNAs ([@B63]; [@B58]; [@B36]; [@B41]). To directly confirm that active ribosomes contain *O*-GlcNAc proteins, we isolated polysomes from HepG2 cells via continuous sucrose gradient centrifugation and analyzed the different fractions using an antibody that specifically recognizes *O*-GlcNAc--modified proteins ([@B11]). We found that both, subpolysomal fractions (represented by the 40S and 60S subunit peaks and the 80S monosome peak) as well as light and heavy polysomes (subunits actively engaged in translation of mRNA) showed many proteins modified with *O*-GlcNAc ([Figure 1](#F1){ref-type="fig"}C, top). Competition experiments performed by preincubating 1 M GlcNAc with the antibody confirmed specificity ([Figure 1](#F1){ref-type="fig"}C, bottom). These results show that several components of the translational machinery are indeed modified with *O*-GlcNAc, even under conditions of active protein synthesis.

Many Core Ribosomal Proteins are O-GlcNAcylated
-----------------------------------------------

We determined the identity of some of the *O*-GlcNAc proteins isolated in our translational preparations. We initially focused our attention on low-molecular-weight species (55 kDa and below), which we hypothesized would represent *O*-GlcNAcylated core ribosomal proteins, and developed a strategy to purify endogenous individual ribosomal proteins ([Figure 2](#F2){ref-type="fig"}A). First, we sedimented total ribosomes by subcellular fractionation and extracted ribosomal proteins from rRNA as described in *Materials and Methods*. Then, the complex mixture of proteins was separated by HPLC on a reverse-phase column yielding multiple peaks over a gradient of mobile organic phase ([Figure 2](#F2){ref-type="fig"}B). The collected fractions were then resolved individually by one-dimensional gel electrophoresis. A general protein stain of the resulting gels showed that the HPLC peaks varied in complexity, some containing only one visible protein band, whereas others contained more than 10 visible species ([Figures 2](#F2){ref-type="fig"}, C and D, and [3](#F3){ref-type="fig"}, A and B). When parallel gels were run, transferred, and blotted with the terminal *O*-GlcNAc--specific lectin sWGA, a large number of these proteins displayed strong reactivity ([Figure 2](#F2){ref-type="fig"}C, top). The presence of *O*-GlcNAcylated proteins in the HPLC fractions was also confirmed by labeling with galactosyltransferase labeling ([Figure 2](#F2){ref-type="fig"}D) and by immunoblotting with an *O*-GlcNAc--specific antibody ([Figure 3](#F3){ref-type="fig"}, A and B).

![Extensive separation of ribosomes allows the detection of multiple individual *O*-GlcNAcylated proteins. (A) Strategy for separation and identification of ribosomal proteins modified with *O*-GlcNAc. (B) Representative chromatogram obtained after HPLC separation of a purified rat liver ribosomal fraction over a reverse-phase C8 column. (C) Reverse-phase HPLC fractions containing ribosomal protein peaks from HeLa cells were separated by one-dimensional gel electrophoresis and subjected to lectin blot (LB) with sWGA (top panels). Fractions were loaded in subsequent order of retention time (early to late from left to right). Comparison with the corresponding G250-stained gel (bottom panels) shows that many, but not all, proteins present in the fractions contain *O*-GlcNAc. Two examples (asterisk and arrowhead) show that the lectin signal for *O*-GlcNAc has different stoichiometries when compared with equivalent levels of total protein. (D) Fractions as in C were subjected to galactosyltransferase labeling in the presence of UDP-\[^3^H\]Gal (top panels). Bottom panels show G250 protein stain of the top panel. No substrate (N), total preparation (previous to RP-HPLC) with galactosyltransferase (+), and total preparation without galactosyltransferase (−) controls are included. Data shown are representative of at least three independent experiments.](zmk0121094710002){#F2}

![Identification of ribosomal proteins modified with *O*-GlcNAc. (A) Reverse-phase HPLC fractions containing ribosomal protein peaks from HeLa cells were separated by one-dimensional gel electrophoresis and subjected to immunoblot (IB) analysis with *O*-GlcNAc-specific antibody (top panels). Fractions were loaded in subsequent order of retention time (early to late from left to right). Corresponding G250-stained gels are shown (bottom panels). Numbered arrowheads show protein bands selected for identification by MS/MS after careful comparison and gel line-up. Identified species are shown in [Table 1](#T1){ref-type="table"}. (B) Same as in A but with rat liver ribosomes. Data shown are representative of \>5 independent experiments.](zmk0121094710003){#F3}

We proceeded to identify some of the modified proteins by carefully lining up the Coomassie-stained bands with the corresponding spot on the *O*-GlcNAc blots, for both HeLa cells and rat liver preparations ([Figure 3](#F3){ref-type="fig"}, A and B). The criteria for selection included: good resolution on the gel and migration as a single band, strong signal on the *O*-GlcNAc blot, and ability to compete with free GlcNAc (not shown). Bands were sliced out of the gel, digested, and identified by tandem mass spectrometry (MS/MS). Proteins with at least two unique and significant peptides are listed in [Table 1](#T1){ref-type="table"}. All of the identified peptides were assigned to ribosomal proteins, corroborating the purity of the original preparation and the efficiency of our separation strategy. Interestingly, some of the identified proteins migrated differently than their predicted molecular mass. In HeLa cells RPL6 and RPSa each migrated at a molecular weight ∼10 kDa higher than their theoretical mass (calculated by the amino acid primary structure). It is important to note that RPL6 and RPSa are known substrates for acetylation and phosphorylation ([@B54]; [@B52]; [@B78]; [@B69]). Therefore, we hypothesize that the observed differences in molecular weights are due to the presence of other PTMs in addition to *O*-GlcNAcylation.

###### 

List of putative *O*-GlcNAcylated ribosomal proteins identified by MS/MS

  Source                        Accesion no.                   Name          MW (Da)   Coverage (%)   No. of peptides
  ----------------------------- ------------------------------ ------------- --------- -------------- -----------------
  HeLa adenocarcinoma (human)                                                                         
      Band 1                    [NP_150644](NP_150644)         RPL8          28,000    52             3
      Band 2                    [NP_001001](NP_001001)         RPS6          28,600    30             2
      Band 3                    [NP_002939](NP_002939)         RPL15         24,000    38             4
      Band 4                    [NP_001019833](NP_001019833)   RPL6          32,800    34             3
      Band 5                    [NP_000959](NP_000959)         RPL4          47,600    31             4
      Band 6                    [NP_000963](NP_000963)         RPL7a/RPS3a   29,900    21             4
      Band 7                    [NP_001012321](NP_001012321)   RPSa          31,700    36             5
  Rat liver                                                                                           
      Band 1                    [P61928](P61928)               RPL37         11,071    23             2
      Band 2                    [P83883](P83883)               RPL36a        12,433    31             4
      Band 3                    [P25886](P25886)               RPL29         17,315    24             3
      Band 4                    [P12749](P12749)               RPL26         17,267    47             7
      Band 5                    [P61354](P61354)               RPL27         15,788    24             3
      Band 6                    [P20280](P20280)               RPL21         18,454    35             5
      Band 7                    [P41123](P41123)               RPL13         24,294    16             3
      Band 8                    [P62914](P62914)               RPS11         18,419    50             8
      Band 9                    [P62755](P62755)               RPS6          28,663    18             5
      Band 10                   [P62755](P62755)               RPS6          28,663    39             6
      Band 11                   [P21533](P21533)               RPL6          33,541    16             6
      Band 12                   [P24049](P24049)               RPL17         21,383    28             4
      Band 13                   [P21531](P21531)               RPL3          46,107    17             5
      Band 14                   [P50878](P50878)               RPL4          47,227    14             8
      Band 15                   [P09895](P09895)               RPL5          34,437    28             9

We decided to map the sites of *O*-GlcNAc modification on rat liver ribosomal proteins by employing a strategy we recently developed ([@B71]). Using ribosomal extracts we were able to identify sites of *O*-GlcNAcylation on four different ribosomal proteins ([Figure 4](#F4){ref-type="fig"}, A--D). These sites are Ser 72 of RPL32 ([Figure 4](#F4){ref-type="fig"}A), Ser 91 of RPL36 ([Figure 4](#F4){ref-type="fig"}B), Ser 265 of RPL6 ([Figure 4](#F4){ref-type="fig"}C), and Ser 66 of RPL29 ([Figure 4](#F4){ref-type="fig"}D). The identification of L36, L6, and L29 as *O*-GlcNAcylated proteins by this method further validates our previous approach based on selection of single ribosomal protein bands that show immunoreactivity with the *O*-GlcNAc antibody.

###### 

MS/MS of the enriched and derivatized peptides identified the sites of *O*-GlcNAc modification on four rat liver ribosomal proteins. (A) Serine 72 of RPL32. (B) Serine 91 of RPL36. (C) Serine 265 of RPL6. The m/z values of the y(5) and y(6) species are 599.48 and 822.5, respectively. (D) Serine 66 of RPL29.
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O-GlcNAcylation of RPS6 Displays Different Dynamics than Phosphorylation in Response to Nutritional Changes
-----------------------------------------------------------------------------------------------------------

RPS6 phosphorylation upon activation of the mTOR signaling pathway has been widely studied ([@B55]). Our screen showed that in both HeLa cells and rat liver RPS6 is *O*-GlcNAcylated. Interestingly, two protein bands that migrate at different molecular weights were identified as RPS6 by MS/MS, suggesting that both the naked and the phosphorylated forms of RPS6 are modified with *O*-GlcNAc ([Figure 3](#F3){ref-type="fig"}, A and B, [Table 1](#T1){ref-type="table"}). We confirmed the identity of both bands by performing Western blot analysis with an antibody specific to RPS6 ([Figure 5](#F5){ref-type="fig"}A). Because *O*-GlcNAcylation and phosphorylation are known to have a dynamic interplay in cells ([@B27]; [@B71], [@B70]; [@B12]; [@B6]), we determined if mutation of the phosphorylation sites on RPS6 ([@B32]; [@B44]; [@B53]) abrogated *O*-GlcNAcylation. We transfected HEK293 cells with plasmids expressing HA, HA-S6 (wild type), HA-S6-S235/236A, and HA-S6-S235/236D. After immunoprecipitation and Western blot analysis, we were able to show that all three forms of the S6 protein are modified with *O*-GlcNAc to similar extents ([Figure 5](#F5){ref-type="fig"}B).

![*O*-GlcNAcylation of RPS6 exhibits different dynamics than nutrient-induced phosphorylation. (A) Reverse-phase HPLC fractions containing rat liver RPS6 visible by G250 and identified by MS/MS were immunoblotted (IB) for *O*-GlcNAc and S6. (B) Lysates from HEK293 cells transfected with HA, HA-S6, HA-S6-S135/236A, or HA-S6-S235/236D were immunoprecipitated (IP) for HA and immunoblotted (IB) for HA and *O*-GlcNAc. (C) Lysates from Neuro-2a cells transfected with HA or HA-S6 were glucose-deprived for the indicated times, immunoprecipitated (IP) for HA, and immunoblotted (IB) for *O*-GlcNAc, HA, phospho-S6 (Ser240/244), and actin. Inputs are shown in the left panel. (D) HEK293 cells transfected with HA or HA-S6 were serum-starved overnight and stimulated with serum (10%) over the indicated times. Lysates were immunoprecipitated (IP) for HA and immunblotted (IB) for HA, *O*-GlcNAc, and phospho-S6 (Ser240/244). The vector-only control (HA) corresponding to 60-min serum stimulation is shown. Data shown are representative of at least three independent experiments.](zmk0121094710005){#F5}

The mTOR pathway is known to integrate signals from nutrients and energy to regulate cell size and metabolism ([@B48]). RPS6 becomes phosphorylated in response to a wide range of nutritional cues, including growth factors and glucose-sensing hormones ([@B30]; [@B48]; [@B53]). We decided to test if *O*-GlcNAcylation of RPS6 also responded to nutritional changes in the environment. We first performed glucose deprivation experiments, which are known to dramatically affect global protein *O*-GlcNAcylation ([@B9]). Surprisingly, although phosphorylation of wild-type HA-S6 decreased rapidly and dramatically in response to glucose starvation, its *O*-GlcNAcylation remained unchanged ([Figure 5](#F5){ref-type="fig"}C). Endogenous S6 coimmunoprecipitated with the HA-tagged S6 construct, indicating that either both forms of RPS6 interact at some point or that HA-S6 incorporates into polysomes and brings down ribosomes containing endogenous RPS6 (only one molecule of S6 is present per small subunit; [@B45]). Glucose deprivation increased the number of *O*-GlcNAcylated high-molecular-weight proteins that interact with HA-S6 at longer times ([Figure 5](#F5){ref-type="fig"}C). We decided to also test the opposite scenario: *O*-GlcNAcylation of S6 under conditions of sudden nutrient abundance. We serum-starved HEK293 cells expressing HA-S6 wild type. Immunoprecipitation of HA-S6 and Western blot analysis showed that *O*-GlcNAcylation remained unchanged, whereas phosphorylation increased rapidly upon serum refeeding ([Figure 5](#F5){ref-type="fig"}D). Our results suggest that the *O*-GlcNAc modification on RPS6 does not follow the same dynamics of phosphorylation, at least under our conditions of nutritional challenge.

O-GlcNAc Cycling Enzymes Associate with Different Populations of Ribosomes
--------------------------------------------------------------------------

Ribosomal proteins are translated in the cytosol, imported into the nucleus, assembled around newly transcribed rRNA in the nucleolus, and exported back into the cytoplasm in the form of mature subunits ([@B3]; [@B19]; [@B5]). Because ribosomal proteins are substrates for *O*-GlcNAcylation, they must interact with OGT and/or OGAse in the cytoplasm, the nucleus/nucleolus, or both. To test this possibility, we purified total ribosomal preparations from rat liver and subjected them to washes with increasing concentrations of salt. After extraction from rRNA and Western blot analysis, we observed that both OGT and OGAse cosedimented with ribosomes, even after a salt wash of 1 M KCl ([Figure 6](#F6){ref-type="fig"}A). Surprisingly, we find that OGT remains associated with the translational machinery even after the high-salt wash has stripped some of the core ribosomal protein S6, which significantly increases the ratio of OGT to ribosomes ([Figure 6](#F6){ref-type="fig"}A, left and right top panels). Transiently associated translation factors are known to dissociate from the ribosome at salt concentrations of 0.5 M ([@B63]; [@B58]; [@B36]; [@B41]), suggesting that the *O*-GlcNAc cycling enzymes associate very strongly with ribosomes. Next, we fractionated actively translating polysomes from HepG2 cells growing under normal conditions and probed these fractions for OGT and OGAse. As shown ([Figure 6](#F6){ref-type="fig"}B), we confirmed that both *O*-GlcNAc cycling enzymes copurify with actively translating ribosomes in the cytosol. Most of the endogenous OGT signal was observed in the subpolysomal populations, whereas OGAse was found in both, subpolysomal fractions and light and heavy polysomes ([Figure 6](#F6){ref-type="fig"}B). When overexpressed, the majority of the OGT signal is still observed at the top of the gradient and associated with subpolysomal fractions; however, a significant amount of the protein is also found to cosediment with polysomes (see [Figure 9](#F9){ref-type="fig"}B). The differential interaction of endogenous OGT and OGAse with various fractions of ribosomes observed here could be biologically significant, but there is the possibility that it could potentially be explained by limitations of the antibodies used.

![*O*-GlcNAc cycling enzymes associate with ribosomes. (A) Total ribosome preparation from rat liver was incubated with increasing concentrations of salt (KCl) as indicated and subjected to an additional round of purification through a sucrose cushion. Ribosomal proteins were extracted with acetic acid, acetone precipitated, separated by electrophoresis, and immunoblotted (IB) for OGT, OGAse, and S6 (top left panel and bottom panel). Densitometry analysis from four independent experiments shows the ratio of ribosome-associated OGT to RPS6 (top right panel), showing a significant difference between the 0.1 and the 0.5 M samples (P = 0.07). Bars in graph represent the values; error bars, SE. NW, no wash; DU, densitometry units; PR, postribosomal fraction. (B) Polysomal fractions from HepG2 cells growing under normal conditions were TCA precipitated, separated by electrophoresis, and subjected to immunoblot (IB) analysis with OGT, OGAse, and S6 antibodies. (SP) subpolysomal fractions. Data shown are representative of at least three independent experiments.](zmk0121094710006){#F6}

Next we wanted to test if the association of OGT and OGAse with ribosomes was exclusive to the cytosolic compartment. We isolated intact nuclei and nucleoli from HeLa cells ([@B3]) and performed biochemical analysis for the presence of *O*-GlcNAc enzymes. Interestingly, whereas most of the OGAse was found in the cytoplasm, a fraction of this protein was also present in the nucleolar preparation ([Figure 7](#F7){ref-type="fig"}A, left and right). Previous studies have reported predominant accumulation of OGAse in the cytosol; however, significant OGAse activity is localized to the nucleus as well ([@B20]; [@B72]). Relative to its levels in the nucleus, OGT was absent from the nucleolus, and it accumulated in the nucleoplasmic fraction ([Figure 7](#F7){ref-type="fig"}A, left and right). To further explore the cytolocalization of the *O*-GlcNAc cycling enzymes, we carried out immunofluorescence studies of the isolated nucleoli. This analysis showed no OGT in the structures labeled with fibrillarin as a nucleolar marker ([Figure 7](#F7){ref-type="fig"}B, bottom). In contrast, endogenous OGAse localizes to nucleoli, surrounding regions labeled with RPS6 as a marker ([Figure 7](#F7){ref-type="fig"}B, top and middle).

![OGAse is present in purified nucleoli. (A) HeLa cells were fractionated into different subcellular components in order to obtain intact nuclei and nucleoli. Equivalent amount of total proteins from the different fractions was separated by electrophoresis and immunoblotted (IB) for tubulin, fibrillarin, OGAse, and OGT (left). Densitometry analysis from four independent experiments shows the amount of OGAse per microgram of protein loaded in every fraction (right). Bars in graph represent the values; error bars, SE. (B) Nucleoli from A were spotted onto coverslips, fixed, permeabilized, and stained for immunofluorescence confocal microscopy with OGAse (red), RPS6 (green), OGT (red), and fibrillarin (green) antibodies. Isotype (red) and secondary (red) controls are included for the OGAse antibody. Magnifications are shown in parenthesis. All pictures in each panel were exposed for equal times and subjected to the same brightness/contrast adjustments. Data shown are representative of at least three independent experiments.](zmk0121094710007){#F7}

To confirm the differential localization of OGT and OGAse in the nucleolus, we performed immunofluorescence experiments on whole cells under conditions of nucleolar stress ([@B3]; [@B33]; [Figure 8](#F8){ref-type="fig"}). Control cells treated with vehicle (DMSO) show that OGAse localizes mostly to the cytosol, but is also present uniformly throughout the nucleus ([Figure 8](#F8){ref-type="fig"}A). Nuclear staining of OGAse is apparent in the nucleoplasm and in subnuclear regions that presumably represent nucleoli ([Figure 8](#F8){ref-type="fig"}A, white arrow). For OGT, most of the signal accumulated in the nucleoplasm, whereas less staining was present in the cytosolic compartment ([Figure 8](#F8){ref-type="fig"}B, top middle panel). Despite its strong nucleoplasmic accumulation, OGT was almost completely excluded from nucleoli, as observed by the lack of colocalization with fibrillarin, which showed its typical granular staining ([Figure 8](#F8){ref-type="fig"}B, top middle panel, left column, and green color in the merge). OGAse colocalization with fibrillarin in control cells is not apparent due to the strong signal generated by the typical granular staining of this nucleolar marker ([Figure 8](#F8){ref-type="fig"}B, top left panel). Nucleolar stress induced by actinomycin D treatment clearly disrupted nucleolar structure as observed by diffusion of fibrillarin into the nucleoplasm, loss of granular staining in the nucleolus, and the appearance of dark regions ([Figure 8](#F8){ref-type="fig"}B, bottom middle panel). This treatment did not affect the distribution or localization of OGT ([Figure 8](#F8){ref-type="fig"}B, top middle panel and bottom panel). In contrast, nucleolar stress changed the distribution of OGAse in the nucleus, which showed a nonuniform staining and the appearance of dark regions that colocalized with the empty nucleolar spaces generated by the diffusion of fibrillarin into the nucleoplasm ([Figure 8](#F8){ref-type="fig"}B, bottom middle panel and white arrows). Concomitantly, colocalization of fibrillarin and OGAse under nucleolar stress increased in the nucleoplasm ([Figure 8](#F8){ref-type="fig"}B, bottom middle panel).

![Nucleolar stress disrupts staining of OGAse in the nucleus of cells. (A) HeLa cells were grown on coverslips, fixed, permeabilized, and stained for immunofluorescence confocal microscopy with OGAse (red) antibody. Nuclear OGAse staining shows a gradient from nucleoplasm to nucleoli (white arrow). Isotype (red) and secondary (red, tubulin shown in green) controls are included. Magnification, ×100. All pictures were exposed for equal times (50 ms) and subjected to the same brightness/contrast adjustments. (B) HeLa cells were subjected to treatments as indicated, processed as in A, and double-stained with OGAse (red) and fibrillarin (green) or OGT (red) and fibrillarin (green) antibodies. OGAse staining in the nucleus follows the same pattern as disrupted fibrillarin (white arrows). Magnifications, ×63 (OGT) and ×100 (OGAse). All pictures in each panel were exposed for equal times and subjected to the same brightness/contrast adjustments. Data shown are representative of at least three independent experiments.](zmk0121094710008){#F8}

Overall, our results indicate that OGT and OGAse strongly and differentially associate with ribosomes at different stages of their maturation process (translating ribosomes and assembling ribosomes).

Overexpression of OGT Causes Accumulation of 60S Subunits and 80S Monosomes
---------------------------------------------------------------------------

Polysome profiles not only provide information about the initiation and elongation status of actively translating ribosomes (monosome to polysome ratio), but also reflect imbalances in subunit populations. We tested whether overexpression of either *O*-GlcNAc cycling enzyme would affect polysome distribution. We infected HepG2 cells with either adenoviral OGT (vOGT), adenoviral OGAse (vOGAse), or adenoviral GFP (vGFP), the latter as a control for infection and overexpression. Forty-eight hours after infection, we obtained whole cell lysates and polysome profiles. Immunoblots showed that infection was efficient as observed by the increased levels of OGT, OGAse, or GFP and increase and decrease in *O*-GlcNAc levels, respectively (compared with vGFP control; [Figure 9](#F9){ref-type="fig"}A). Analysis of polysome profiles from vGFP control and OGAse-overexpressing cells showed two smaller peaks for 40S and 60S subunits and a relatively taller peak for 80S monosomes, as well as polysomes ([Figure 9](#F9){ref-type="fig"}B, left and right panels). However, overexpression of OGT caused a dramatic increase in the size of the 60S peak ([Figure 9](#F9){ref-type="fig"}B, middle panel, arrowhead) and the 80S peak ([Figure 9](#F9){ref-type="fig"}B, middle panel, arrow) when compared with vGFP and vOGAse. Immunoblot analysis showed that when overexpressed, both OGT and OGAse increase their association with polysomes. Taken together, our data suggest that *O*-GlcNAc cycling may play a role in ribosomal subunit homeostasis.

![Adenoviral-mediated overexpression of OGT causes accumulation of 60S subunits and 80S monosomes. (A) HepG2 cells were infected with adenovirus overexpressing either GFP control, OGT, or OGAse. Lysates were obtained after 48 h and immunoblotted (IB) for *O*-GlcNAc, OGT, OGAse, GFP, and actin to determine efficiency of overexpression. (B) HepG2 cells were infected as in A and polysome profiles were obtained 48 h after infection. Cells overexpressing OGT (vOGT) show an increase in the 60S (arrowhead) and the 80S (arrow) peaks as compared with vOGAse and vGFP control. Polysomal fractions were TCA precipitated, separated by electrophoresis, and subjected to immunoblot analysis with OGT, OGAse, and S6 antibodies. Data shown are representative of three independent experiments.](zmk0121094710009){#F9}

DISCUSSION
==========

The ribosome is the most complex universal ribonucleoprotein machine ([@B19]; [@B34]). In this work, we have added a new level of complexity, the presence of a single β-*N*-acetylglucosamine monosaccharide attached in *O*-linkage to its core ribosomal proteins. We have identified ribosomal proteins Sa, S6, and S11 from the small subunit and L3, L4, L5, L6, L8, L13, L15, L17, L21, L26, L27, L29, L32, L36, L36a, and L37 from the large subunit as being modified with *O*-GlcNAc under conditions of normal cellular growth and active translation. In addition, either or both S3 and L7a are also *O*-GlcNAcylated; however, these two proteins migrate together during reverse-phase separation and gel electrophoresis, making it difficult to single out the *O*-GlcNAc immunoreactive band. *O*-GlcNAcylation of ribosomal proteins L8, L17, and L21 has been previously reported using a Click-iT chemistry tagging methodology in total MCF-7 cell extracts ([@B23]). *O*-GlcNAcylation of S3 and L13a has also been reported by metabolic labeling with UDP-GlcNAz ([@B42]). This latter report also suggests that ribosomal proteins S11, L6, and L36a-like are modified by *O*-GlcNAc after their immunoprecipitation with an *O*-GlcNAc antibody ([@B42]). More recently, the generation of a highly specific mAb against *O*-GlcNAcylated epitopes allowed the immunopurification of several ribosomal proteins ([@B66]). Our direct experimental approach of purifying preparations enriched in components of the translational machinery and applying several levels of biochemical separation has allowed us to directly identify 20 *O*-GlcNAcylated ribosomal proteins of which eight are newly reported. Along with previous observations, our findings bring the *O*-GlcNAc-ribosomal proteome to 34 proteins out of approximately 80 that comprise the mammalian ribosome.

Site mapping constitutes a more definitive approach of assigning PTMs to any given protein. In this work, we identified the amino acid residues to which *O*-GlcNAc is covalently attached in four of the mammalian ribosomal proteins. We report that Ser 265 of L6, Ser 66 of L29, Ser 72 of L32, and Ser 91 of L36 are modified by *O*-GlcNAc. Of these four proteins, only the sequence containing the O-GlcNAcylated residue in L32 is included within the known structure of a mammalian 80S complex recently solved at 8.7 Å by electron cryomicroscopy and single-particle methods ([@B8]). Using the software PyMOL (DeLano Scientific, South San Francisco, CA), we have located the Serine 72 residue of the L32 polypeptide on a kink that is exposed to the solvent, but also is in close proximity with rRNA (not shown). This interesting location makes the *O*-GlcNAcylated residue of L32 available for dynamic modification under changing conditions and suggests that *O*-GlcNAc may play a structural role on the ribosome, helping to stabilize the entire mature complex and perhaps contributing to its ribozyme activity.

Assigning individual functions to ribosomal proteins has been a very difficult task for more than 50 years. Of the proteins identified in our analyses, studies in yeast have shown that S6, S11, L4, L5, and L8 are essential for cell viability, whereas L29 is a nonessential ribosomal protein ([@B19]). S6, L8, and L29 are unique to eukaryotes, whereas L4, L5, and S11 have homologues in archaea ([@B19]). *O*-GlcNAcylation of ribosomal proteins could impact the role of these components as a whole complex and thus have implications on overall ribosome performance. In addition, *O*-GlcNAc may have an influence on extra-ribosomal functions of individual proteins. In fact, the occurrence of other PTMs on ribosomal proteins has been functionally linked to activities independent of their roles as components of the ribosome. For example, ribosomal protein L26 binds to the 5′ untranslated region of the p53 mRNA and controls p53 translation and induction upon damage to DNA ([@B65]). Ribosomal protein L6, also known as TaxREB107, contains a DNA-binding motif and may be involved in transactivation of transcription of human T-cell leukemia virus type I ([@B37]). Another intriguing ribosomal protein, Sa, is the monomeric precursor of the 67-kDa laminin receptor dimer. Sa is a multifunctional protein that interacts with alphaviruses and prions at the cell surface and is also involved in metastasis of solid tumors. Interestingly, Sa is required to be acylated in order to become the cell surface laminin receptor ([@B74]; [@B50]; [@B7]; [@B51]; [@B21]; [@B29]). One common property to all of these proteins is that they exist as separate cytosolic pools dissociated from the ribosome. It is possible that *O*-GlcNAcylation functions as a biochemical tag to help maintain these separate populations of the same protein species.

Here we also report that the widely studied ribosomal protein S6, a constituent of the mTOR pathway, is modified with *O*-GlcNAc. In response to mitogens and growth factors, S6 becomes phosphorylated by various kinases at five distinct serine residues clustered in its C-terminus ([@B55]; [@B53]). It was postulated that the physiological consequence of these phosphorylation events was to control the translation of 5′ tract of oligopyrimidine (TOP)-mRNAs, which encode numerous components of the translational apparatus ([@B55]). However, a breakthrough study showed that knockin mutations at all five phosphorylatable residues of RPS6 do not affect translation of TOP-mRNAs, but rather increase global protein synthesis, accelerate cell division, and result in smaller cell size ([@B56]). More interestingly, these mutations have a profound deleterious effect on glucose homeostasis in several tissues ([@B56]). It has been well established that deregulation of glucose metabolism increases protein GlcNAcylation of several key components of the insulin signaling pathway ([@B17]). The sites of *O*-GlcNAc modification on RPS6 have yet to be determined; however, we hypothesize that the *O*-GlcNAcylated form of RPS6 may play a role in regulating glucose metabolism in cells.

In mammalian cells, ribosomal protein S6 is also required for biogenesis of the small ribosomal subunit and maintenance of the size of the free 40S cytosolic pool ([@B68]; [@B43]). L29, another ribosomal protein found to be *O*-GlcNAcylated at Ser 66 in our study, is also important for the assembly of large ribosomal subunits ([@B16]). In this work, we present evidence that the *O*-GlcNAc modification may in fact play a role in ribosome biogenesis. We showed that OGAse colocalized in the nucleolus with fibrillarin, a ribosome-assembly processing factor ([@B67]), whereas OGT was excluded from the nucleolus. OGAse nuclear distribution was sensitive to nucleolar disruption treatments that caused redistribution of fibrillarin to the nucleoplasm, suggesting that OGAse may transiently associate with nucleolar resident proteins. OGAse has been shown to directly interact with ATP-dependent RNA helicase A, a protein that resides in the nuclear/nucleolar compartment and participates in the biogenesis of the eukaryotic 60S subunit ([@B62]). Moreover, increasing the levels of OGT caused an accumulation of the 60S peak, pointing at a role for *O*-GlcNAc cycling in large subunit assembly. The process of subunit biogenesis is different for small and large subunits. Although 40S particles are entirely assembled in the nucleolus, the late stages of 60S particle assembly take place in the nucleoplasm and in the cytoplasm ([@B5]). We hypothesize that the role of the *O*-GlcNAc--cycling enzymes on ribosome assembly is dependent on their ability to differentially localize to the nucleus/nucleolus. In addition, the mechanisms by which OGT is kept predominantly in the nucleoplasm and is excluded from the nucleolus are very intriguing.

Our results also show that adenoviral-mediated OGT overexpression caused an accumulation of 80S monosomes, which is suggestive of a role for OGT in keeping an active translational apparatus during viral infection. A role for OGT during cellular stress has been previously documented by our laboratory ([@B80]). OGT activity and global *O*-GlcNAcylation of proteins increase drastically and dynamically under a wide variety of stress, and these events are required for recovery and survival of the cells. A recent study shows that OGT directly participates in formation of stress granules under conditions of arsenite treatment and which OGT correlates with a general increase in the *O*-GlcNAcylation of ribosomal proteins ([@B42]). This study also shows that *O*-GlcNAc is present in proteins that form the stress granules ([@B42]). These data support our hypothesis that *O*-GlcNAc may serve as a biochemical tag for assigning ribosomal proteins new functions or subcellular locations under changing environmental conditions.

With this work, we have opened a new area of study on the possible role of *O*-GlcNAcylation and its cycling enzymes in the translational control of gene expression. Future research should be dedicated to establishing the functions of OGT, OGAse and *O*-GlcNAcylated ribosomal proteins in ribosome structure and performance, extraribosomal functions of ribosomal proteins, biogenesis of 40S and 60S particles, and control of polysomal populations and translation.
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:   β-elimination followed by Michael addition with dithiothreitol
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:   eukaryotic initiation factor 2
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:   *O*-GlcNAc-thiazoline
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:   mammalian target of rapamycin
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*O*-GlcNAc

:   O-linked β-*N*-acetylglucosamine

OGT
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